ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Possible delayed diagnosis and treatment of metastatic differentiated thyroid cancer by adopting the 2015 ATA guidelines

Albano, Domenico*; Bertagna, Francesco; Bonacina, Mattia; Durmo, Rexhep; Cerudelli, Elisabetta; Gazzilli, Maria; Panarotto, Maria Beatrice; Formenti, Anna Maria; Mazziotti, Gherardo; Giustina, Andrea; Giubbini, Raffaele
European Journal of Endocrinology2018-9DOI: 10.1530/EJE-18-0253
35被引5阅读
引用收藏
分享

摘要

Objective: According to the 2015 American Thyroid Association (ATA) guidelines, thyroid ablation by iodine-131 (I-131) therapy is absolutely recommended only in patients with high-risk differentiated thyroid cancer (DTC). Often distant metastases are not recognized early and they can stay silent for long time. The aim of our study was to retrospectively analyze the prevalence of metastatic disease before and after I-131 and to evaluate the influence of the new ATA guidelines in the management of DTC. Methods: We retrospectively analyzed 140 patients showing distant metastases. All metastases were detected by whole-body scan after I-131 and confirmed by histology and/or other imaging modalities. Results: In 26/140 patients metastases were detected before I-131, while in 114/140 were discovered after I-131. Comparing patients with metastases detected before and after I-131, no differences were demonstrated considering age, sex, histotype, tumor size, multifocality of cancer and metastatic localization. Metastatic DTC discovered before radioiodine had higher thyroglobulin and received a higher radioiodine total activity and number of treatments. Considering patients with distant metastases, according to the 2015 ATA guidelines, 38 patients would have been categorized as high risk, 22 as low risk and 80 as intermediate risk. Among intermediate-risk patients, only in 25 cases (31%) I-131 treatment would have been appropriate according to 2015 ATA recommendations; in the remaining 56 cases (69%), I-131 would not have been recommended. Conclusions: According to the 2015 ATA guidelines, most of metastatic patients would not have been treated after surgery, with the risk of late diagnosis and delayed treatment.

学科与关键词

关键词
ASSOCIATION MANAGEMENT GUIDELINESPREABLATION 131-I SCANSPULMONARY METASTASESRADIOIODINE ABLATIONSTATISTICAL-ANALYSISDISTANT METASTASESADULT PATIENTSI-131 THERAPYCARCINOMATHYROGLOBULIN
相关
加载中…
  • Clinical outcomes of a cohort of 271 patients with lung metastases from differentiated thyroid carcinoma
    Maciel, Joana*; Cavaco, Daniela; Silvestre, Catarina; Pereira, Joana Simoes; Vilar, Helena; Leite, ValerianoClinical Endocrinology, 2022, 97(6): 814-821.被引 3
  • Incorporation size of lymph node metastasis focus and pre-ablation stimulated Tg could more effectively predict clinical outcomes in differentiated thyroid cancer patients without distant metastases
    Xie, Jiahao; Chen, Pan; Wang, Jing; Luo, Xiaoqin; Luo, Jiaxin; Xiong, Xiaoli; Li, Chunyan; Pan, Liqin; Wu, Juqing; Feng, Huijuan; Ouyang, Wei*Frontiers in Endocrinology, 2023, 14: 1094339.被引 1
  • Incorporation size of lymph node metastasis focus and pre-ablation stimulated Tg could more effectively predict clinical outcomes in differentiated thyroid cancer patients without distant metastases (vol 14, 1094339, 2023)
    Xie, Jiahao; Chen, Pan; Wang, Jing; Luo, Xiaoqin; Luo, Jiaxin; Xiong, Xiaoli; Li, Chunyan; Pan, Liqin; Wu, Juqing; Feng, Huijuan; Ouyang, Wei*Frontiers in Endocrinology, 2023, 14: 1221004.
查看全部 →

发表信息

论文状态
公开发表
期刊
European Journal of Endocrinology
发表日期
2018-09
卷期
第 179 卷, 第 3 期
页码
143-151
DOI
10.1530/EJE-18-0253
语言
ENGLISH
期刊等级
Q1
成果收录
SCIE

作者

  • A

    Albano, Domenico (通讯) (第一作者)

  • B

    Bertagna, Francesco

查看全部 11 位作者收起作者
  • B

    Bonacina, Mattia

  • D

    Durmo, Rexhep

  • C

    Cerudelli, Elisabetta

  • G

    Gazzilli, Maria

  • P

    Panarotto, Maria Beatrice

  • F

    Formenti, Anna Maria

  • M

    Mazziotti, Gherardo

  • G

    Giustina, Andrea

  • G

    Giubbini, Raffaele

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417